Standard InChI: InChI=1S/C34H46N10O3/c35-27(13-7-19-40-33(36)37)30(45)44-29(21-23-15-17-26(18-16-23)25-11-5-2-6-12-25)32(47)43-28(14-8-20-41-34(38)39)31(46)42-22-24-9-3-1-4-10-24/h1-6,9-12,15-18,27-29H,7-8,13-14,19-22,35H2,(H,42,46)(H,43,47)(H,44,45)(H4,36,37,40)(H4,38,39,41)/t27-,28-,29-/m0/s1
1.Svenson J, Brandsdal BO, Stensen W, Svendsen JS.. (2007) Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect., 50 (14):[PMID:17569519][10.1021/jm0703542]
2.Karstad R, Isaksen G, Brandsdal BO, Svendsen JS, Svenson J.. (2010) Unnatural amino acid side chains as S1, S1', and S2' probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation., 53 (15):[PMID:20608742][10.1021/jm1006337]
3.Flaten GE, Kottra G, Stensen W, Isaksen G, Karstad R, Svendsen JS, Daniel H, Svenson J.. (2011) In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides., 54 (7):[PMID:21401113][10.1021/jm1015704]
4.Karstad R, Isaksen G, Wynendaele E, Guttormsen Y, De Spiegeleer B, Brandsdal BO, Svendsen JS, Svenson J.. (2012) Targeting the S1 and S3 subsite of trypsin with unnatural cationic amino acids generates antimicrobial peptides with potential for oral administration., 55 (14):[PMID:22720778][10.1021/jm3002058]